The GLP-1 (Ozempic/Wegovy) Litigation Roadmap: Managing Long-Term Gastric Complications & “Eye Stroke” Surge
Explore the 2026 GLP-1 Litigation roadmap. Analyzing MDL 3094 for Ozempic stomach paralysis and NAION eye stroke claims. A must-read for personal injury attorneys and high-risk patients. If you’ve been following the meteoric rise of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro, you know the narrative has shifted. What began as a “miracle” weight-loss … Read more